Skip to main content
. 2021 Jan 1;18(3):615–625. doi: 10.7150/ijms.51589

Figure 4.

Figure 4

MiR-34c agomir promotes hepatic fibrosis and inhibits liver lipogenesis in rats. (A) Liver Masson trichrome staining in the normal control group, DMN model group, DMN model group, and the administration group was 100× for 2 weeks and 3 weeks; arrows point to the liver fibrosis areas. (B) Hepatic Masson trichrome stain and Sudan black stain in the DMN model group + administration group and normal control group at 4 weeks after administration. 100×, 200×, 400×, arrows indicate liver fibrosis areas.